Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus

  • Burçe Orman
  • , Semra Çetinkaya
  • , Nergiz Öner
  • , Meltem Akçaboy
  • , Ali Fettah
  • , Naz Güleray Lafcı
  • , Şenay Savaş Erdeve

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Abstract

Glucose 6 phosphate dehydrogenase (G6PD) is expressed in all tissues and is necessary to maintain oxidant stress capacity of cells. G6PD deficiency is the most common enzymopathy in humans and is among the important causes of hemolytic anemia. It has been reported that severe hemolytic anemia due to G6PD deficiency may develop in newly diagnosed diabetes, especially during the correction of hyperglycemia. To date, nine cases have been published. Genetic analysis was not performed for G6PD deficiency in these published patients. We present a case of hemolytic anemia due to G6PD deficiency secondary to newly diagnosed type 1 diabetes mellitus. Genetic testing was performed for the index patient and revealed a previously reported missense pathogenic variant (c.653C>T; p.Ser218Phe) in the G6PD gene.

Original languageEnglish
Pages (from-to)417-420
Number of pages4
JournalJCRPE Journal of Clinical Research in Pediatric Endocrinology
Volume15
Issue number4
DOIs
Publication statusPublished - 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Diabetes mellitus
  • G6PD
  • anemia

Fingerprint

Dive into the research topics of 'Hemolytic Anemia due to Glucose 6 Phosphate Dehydrogenase Deficiency Triggered by Type 1 Diabetes Mellitus'. Together they form a unique fingerprint.

Cite this